AU2003300984A1 - Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative - Google Patents

Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Info

Publication number
AU2003300984A1
AU2003300984A1 AU2003300984A AU2003300984A AU2003300984A1 AU 2003300984 A1 AU2003300984 A1 AU 2003300984A1 AU 2003300984 A AU2003300984 A AU 2003300984A AU 2003300984 A AU2003300984 A AU 2003300984A AU 2003300984 A1 AU2003300984 A1 AU 2003300984A1
Authority
AU
Australia
Prior art keywords
alendronate
phosphonate
vitamin
bis
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003300984A
Other versions
AU2003300984A8 (en
Inventor
Moshe Flashner-Barak
Itzhak E. Lerner
Vered Rosenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2003300984A1 publication Critical patent/AU2003300984A1/en
Publication of AU2003300984A8 publication Critical patent/AU2003300984A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2003300984A 2002-12-16 2003-12-16 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative Abandoned AU2003300984A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US43368502P 2002-12-16 2002-12-16
US60/433,685 2002-12-16
US46020603P 2003-04-02 2003-04-02
US60/460,206 2003-04-02
PCT/US2003/040174 WO2004058235A2 (en) 2002-12-16 2003-12-16 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Publications (2)

Publication Number Publication Date
AU2003300984A1 true AU2003300984A1 (en) 2004-07-22
AU2003300984A8 AU2003300984A8 (en) 2004-07-22

Family

ID=32685268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003300984A Abandoned AU2003300984A1 (en) 2002-12-16 2003-12-16 Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative

Country Status (7)

Country Link
JP (3) JP2006514695A (en)
AU (1) AU2003300984A1 (en)
DE (1) DE10393906T5 (en)
GB (1) GB2411116B (en)
HK (1) HK1078802A1 (en)
IL (1) IL169127A0 (en)
WO (1) WO2004058235A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1993559T3 (en) 2006-02-03 2017-01-31 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
US7749536B2 (en) * 2006-02-14 2010-07-06 Teva Pharmaceutical Industries Ltd. Pharmaceutical formulations of aliphatic amine polymers and methods for their manufacture
LT2679228T (en) 2006-06-21 2018-05-10 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D repletion agent and vitamin D hormone replacement agent
AU2007335155A1 (en) * 2006-12-20 2008-06-26 Mylan Pharmaceuticals Ulc A composition containing a bisphosphonic acid in combination with vitamin D
AU2007335156A1 (en) * 2006-12-20 2008-06-26 Mylan Pharmaceuticals Ulc Pharmaceutical composition comprising a hot-melt granulated lubricant
JP5647516B2 (en) 2007-04-25 2014-12-24 シトクロマ インコーポレイテッド Methods and compounds for vitamin D therapy
WO2008134512A1 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Oral controlled release compositions comprising vitamin d compound and waxy carrier
KR101495578B1 (en) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 Method of treating vitamin d insufficiency and deficiency
JP2010525080A (en) 2007-04-25 2010-07-22 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー Safe and effective treatment and prevention method for secondary hyperparathyroidism in chronic kidney disease
ES2954932T3 (en) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Useful methods, compositions, uses and kits for vitamin D deficiency and related disorders
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
CR20170085A (en) 2014-08-07 2017-04-25 Opko Ireland Global Holdings Ltd ADJUNCTIVE THERAPY WITH 25-HYDROXY VITAMIN D
JP7032322B2 (en) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド Vitamin D treatment
CN109364034B (en) * 2018-11-26 2021-05-04 正大制药（青岛）有限公司 Calcitriol preparation and preparation method thereof
CN116211818B (en) * 2023-03-10 2024-04-09 菲洋生物科技(吉林)有限公司 Tablet containing alendronate sodium and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
US20030158154A1 (en) * 2001-07-17 2003-08-21 Moshe Fleshner-Barak Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate

Also Published As

Publication number Publication date
HK1078802A1 (en) 2006-03-24
WO2004058235A3 (en) 2005-02-24
WO2004058235A2 (en) 2004-07-15
JP2006514695A (en) 2006-05-11
DE10393906T5 (en) 2006-01-12
JP2014205711A (en) 2014-10-30
GB0511750D0 (en) 2005-07-20
JP2011241221A (en) 2011-12-01
GB2411116B (en) 2009-04-29
GB2411116A (en) 2005-08-24
AU2003300984A8 (en) 2004-07-22
IL169127A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
IL169127A0 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
AU2003280373A1 (en) Method of administering bisphosphonates
AU2003211376A1 (en) Drug administration method
AU2003272590A1 (en) Method for ophtalmic administration of medicament
AU2003296897A1 (en) Pharmaceutical formulations of camptothecine derivatives
AU2002244881A1 (en) Controlled release drug delivery system of pravastatin
EP1585500B8 (en) Coated particles for sustained-release pharmaceutical administration
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
AU2003270486A1 (en) Tie-back connection for subsea well
EP1683525A4 (en) Sustained-release phenylalanine derivative preparation for oral administration
AU2003220917A1 (en) Phospholipid derivative
AU2002223548A1 (en) Improved method for the biosynthesis of vitamin e
AU2003284758A1 (en) Method for preparing oltipraz
AU2003294837A1 (en) Improved method for the production of vitamin b12
AU2003269050A1 (en) Method for decreasing bioavailability variability of an orally administered medicine
AU2003302116A1 (en) Method of preparation of derivatives of substituted 2-aryl aikanoic acids
AU2003252337A1 (en) Patch for transdermal administration
AU2003244092A1 (en) 1ss-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
AU2003269632A1 (en) Multilamellar system for the administration of active agents by means of ingestion
EP1526838B8 (en) Intravenous pharmaceutical form of administration
AU2003242470A1 (en) 1-carboxymethyl analogues of glucosyl lipid a
AU2003200836A1 (en) Method for the preparation of matairesinol
AU2002308823A1 (en) A method of preparing phosphoric ester
AU2003257814A1 (en) Medicinal composition for lowering blood lipid level
AU2003226696A1 (en) Improved method for the production of vitamin b12

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase